DaVita Inc. 1st Quarter 2025 Results
DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter ended March 31, 2025. “Our strong first quarter performance demonstrates the stability and consistency of our…
This content is available for reuse with permission. If you are interested in reusing this content, please email newsroom@davita.com.
DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter ended March 31, 2025. “Our strong first quarter performance demonstrates the stability and consistency of our…
DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss first quarter results on Monday, May 12, 2025, at 5:00 p.m. Eastern Time. The company plans to…
For new patient admissions requests and urgent inquiries, call 1-888-920-6577. Please note that due to higher call volumes, you may be prompted to leave a voicemail. For any medical records,…
Kidney disease affects an estimated 35 million Americans, with 90% unaware until it’s critical. As DaVita celebrates its 25th anniversary, it remains dedicated to changing this by prioritizing…
DaVita Inc. (NYSE: DVA) today announced that its chief financial officer, Joel Ackerman, and its group vice president of investor relations, Nic Eliason, will participate in a fireside chat with…